|
|
||||||||
Ann Thorac Surg 2001;71:439-442
© 2001 The Society of Thoracic Surgeons
a Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan
b Endoscopy Divisions, National Cancer Center Hospital, Tokyo, Japan
Accepted for publication July 19, 2000.
Address reprint requests to Dr Kondo, Thoracic Surgery Division, National Cancer Center Hospital, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan
e-mail: hrkondoh{at}ncc.go.jp
| Abstract |
|---|
|
|
|---|
Methods. Twenty patients underwent this procedure for 21 small peripheral pulmonary lesions approximately 10 mm in size.
Results. All the lesions were successfully marked and identified during fluoroscopy-assisted thoracoscopy. They were resected with sufficient margins. There were no complications related to this procedure. The pathologic examination of these 21 lesions revealed primary lung cancer in 14, atypical adenomatous hyperplasia in four, a metastatic tumor in one, and a benign tumor in two.
Conclusions. This procedure is both a reliable and minimally invasive technique in thoracoscopic wedge resection for small peripheral pulmonary lesions.
| Introduction |
|---|
|
|
|---|
We have already reported a new preoperative marking technique using barium sulfate injected through bronchoscopy under CT guidance followed by fluoroscopy-assisted thoracoscopic wedge resection [9]. With a review of the cases applied, we herein describe the safety and the reliability of this procedure: fluoroscopy-assisted thoracoscopic surgery after CT-guided bronchoscopic barium marking (FATS-BM).
| Patients and methods |
|---|
|
|
|---|
Technique of localization
An endoscopist performed the preoperative localization in a room equipped with CT (X vision; Toshiba Corporation, Tokyo, Japan). The procedure was basically the same as previously reported [9]. 1) The anatomical location of the target lesion was examined by thin-section CT (2-mm collimation). 2) Thin videobronchoscopes (EB-1530T2 and EB-1530T; Asahi Optical Co, Ltd, Tokyo, Japan) with a 5.3-mm distal rigid portion diameter were mainly used in addition to the FUR-9P ultra-thin fiberscope in one case. The bronchoscopes were inserted orally under local anesthesia and the tracheobronchial lumen was examined. 3) A transbronchial aspiration cytology (TBAC) needle (Olympus Optical Co, Ltd, Tokyo, Japan) was inserted into the target bronchus and was guided to the possible lesion site fluoroscopically, which was assessed by high-resolution CT before the procedure. The TBAC needle was prepared by inserting the inner catheter into the outer catheter after removing the needle tip of the inner catheter. In one case, only the inner catheter with its needle tip removed was used coupled with the ultra-thin fiberscope. 4) The patient was transferred into the CT scanner and the three-dimensional relation of the lesion and the tip of the TBAC needle was assessed by high-resolution CT with a 2-mm collimation. 5) When the tip of the TBAC needle was considered to have reached a target area such as that in the proximity of the lesion, 0.1 to 1.0 mL of 50 to 150 w/v% of barium sulfate suspension (Fushimi Pharmaceutical Co, Ltd, Kagawa Japan) was instilled into the bronchus under CT fluoroscopy guidance [9]. 6) Subsequently, the three-dimensional relation of the barium marker and the lesion was ascertained by high-resolution CT. The procedure was completed after fluoroscopically confirming the clarity of the barium marker (Fig 1).
|
|
| Results |
|---|
|
|
|---|
The average lesion size was 10 mm (range 5 to 17 mm) in the greatest dimension. Pathological examinations revealed the 21 lesions to be primary adenocarcinoma in 14, atypical adenomatous hyperplasia in four, and pulmonary metastasis from esophageal cancer, hamartoma, and inflammation in one each. Margins of the specimens were negative in all cases. There was no difficultly in making a pathological diagnosis due to the affection of the barium injection. Of 14 cases with primary lung cancer, 10 cases revealed localized bronchioloalveolar carcinoma (BAC) without an invasive component by frozen section. On the basis of the excellent prognosis of this type of adenocarcinoma [10], we decided to follow up these patients instead of an additional completion lobectomy with consent, excluding 1 patient who underwent a lobectomy. The remaining 4 patients were diagnosed as localized BAC with an invasive component. In the 2 patients diagnosed by frozen section, 1 patient subsequently underwent a curative lobectomy and the other underwent no more resection because of the risk. Another 2 patients were diagnosed by permanent preparation, and we elected careful follow-up instead of reoperation for a curative lobectomy with consent.
The chest tube was removed on 1.5 postoperative days on average (range 1 to 4 days). There was no recurrence in all 14 patients with primary lung cancer on average follow-up of 616 days (range 53 to 1,073 days).
| Comment |
|---|
|
|
|---|
Several types of marking techniques for thoracoscopic resection of small pulmonary nodules were reported. We reviewed representative reports from the standpoint of failure of identification and complications. In the transthoracic hook-wire injection, wire dislodgement occurred in 4% to 20% of the cases and failure of intraoperative identification in 0% to 5% [5, 1214]. In the localization by dye injection, failure of intraoperative identification occurred in 0% to 7% of the cases because of the diffusion of dye or severe anthracosis of the visceral pleura [6, 15]. Because these procedures were basically the percutaneous needling technique, pneumothorax was inevitable, which occurred in 4% to 50% of the cases. In addition, there are some latent possibilities of implantation along the needle tract [16] and fatal air embolization [17]. With regard to the pathological examination, an injected marker or secondary hematoma originating from these procedures may disturb the diagnosis of complicated cases. Although intraoperative ultrasonography is considered safe, it is difficult to detect small and radiographically faint lesions by this procedure. In patients with obstructive lung disease such as emphysema, completely deflating the lung would be difficult. In such cases, intraoperative ultrasonography may be limited [8].
We have developed a new marking technique using barium sulfate followed by thoracoscopic resection under fluoroscopic guidance. In addition, we have applied this procedure to 21 lesions of 20 patients with small peripheral pulmonary lesions and confirmed its safety and reliability. According to an animal experiment, barium sulfate showed low histologic damage [18]. Furthermore, it has a feature of long retention [19], which can avoid the loss of the lesion due to marker diffusion. In addition, the marking procedure does not need to coordinate with the operating room schedule. The practical application of barium sulfate as a substitute for dye, which is injected by the percutaneous needle procedure, has been reported [20]. In our procedure, barium sulfate was administered via the transbronchial route to avoid complications such as pneumothorax, secondary hematoma, and the intravascular injection of the substance originating in needling. Because pneumothorax will basically never occur, this procedure is applicable to the lesion located near the interlober or mediastinal region and multiple or bilateral lesions. Because barium sulfate was located exactly central to the lesion under CT guidance, we could resect the lesion with a sufficient surgical margin. Furthermore, the damage of the specimen resulting from marking and/or resection is minimal. It is an important advantage compared with the needling procedure in diagnosing small and subtle lesions.
FATS-BM is a more reliable and less invasive technique than others previously reported. It is a useful method for not only diagnosis but also therapeutic wedge resection in selected early lung cancer.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Miyoshi, S. Toyooka, H. Gobara, T. Oto, H. Mimura, Y. Sano, S. Kanazawa, and H. Date Clinical outcomes of short hook wire and suture marking system in thoracoscopic resection for pulmonary nodules Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 378 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ikeda, H. Nomori, T. Mori, H. Kobayashi, K. Iwatani, K. Yoshimoto, and K.-i. Kawanaka Impalpable Pulmonary Nodules With Ground-Glass Opacity: Success for Making Pathologic Sections With Preoperative Marking by Lipiodol Chest, February 1, 2007; 131(2): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Watanabe, H. Nomori, T. Ohtsuka, M. Kaji, T. Naruke, and K. Suemasu Usefulness and complications of computed tomography-guided lipiodol marking for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules: Experience with 174 nodules. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 320 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mawatari, A. Watanabe, H. Ohsawa, T. Abe, and G. Yamada Transbronchial Localization of Small Pulmonary Lesions for Thoracoscopic Resection Asian Cardiovasc Thorac Ann, June 1, 2006; 14(3): e48 - e49. [Abstract] [Full Text] [PDF] |
||||
![]() |
Fluoroscopy-assisted thoracoscopic resection of pulmonary nodules after computed tomography-guided bronchoscopic metallic coil marking. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 704 - 710. |
||||
![]() |
H. Asamura, T. Kameya, Y. Matsuno, M. Noguchi, H. Tada, Y. Ishikawa, T. Yokose, S.-X. Jiang, T. Inoue, K. Nakagawa, et al. Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum J. Clin. Oncol., January 1, 2006; 24(1): 70 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Asano, J. Shindoh, K. Shigemitsu, K. Miya, T. Abe, M. Horiba, and Y. Ishihara Ultrathin Bronchoscopic Barium Marking With Virtual Bronchoscopic Navigation for Fluoroscopy-Assisted Thoracoscopic Surgery Chest, November 1, 2004; 126(5): 1687 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Daniel, T. A. Altes, P. K. Rehm, M. B. Williams, D. R. Jones, A. V. Stolin, and S. B. Gay A novel technique for localization and excisional biopsy of small or Ill-defined pulmonary lesions Ann. Thorac. Surg., May 1, 2004; 77(5): 1756 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Endo, Y. Kotani, M. Satouchi, Y. Takada, T. Sakamoto, N. Tsubota, and H. Furukawa CT Fluoroscopy-Guided Bronchoscopic Dye Marking for Resection of Small Peripheral Pulmonary Nodules Chest, May 1, 2004; 125(5): 1747 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Booton, M Jones, and N Thatcher Lung cancer * 7: Management of lung cancer in elderly patients Thorax, August 1, 2003; 58(8): 711 - 720. [Full Text] [PDF] |
||||
![]() |
K. Sugi, Y. Kaneda, K. Hirasawa, and N. Kunitani Radioisotope Marking Under CT Guidance and Localization Using a Handheld Gamma Probe for Small or Indistinct Pulmonary Lesions Chest, July 1, 2003; 124(1): 155 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Partik, A. N. Leung, M. R. Muller, M. Breitenseher, F. Eckersberger, G. Dekan, T. H. Helbich, and V. Metz Using a Dedicated Lung-Marker System for Localization of Pulmonary Nodules Before Thoracoscopic Surgery Am. J. Roentgenol., March 1, 2003; 180(3): 805 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nomori, H. Horio, T. Naruke, and K. Suemasu Fluoroscopy-assisted thoracoscopic resection of lung nodules marked with lipiodol Ann. Thorac. Surg., July 1, 2002; 74(1): 170 - 173. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |